HOME >> MEDICINE >> NEWS
The hunt for a hepatitis C vaccine is under way at Saint Louis University School of Medicine

ST. LOUIS Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.

Now a new trial -- much larger than these two earlier studies -- is about to start at Saint Louis University. Two hundred volunteers are needed, and SLU is the only site in the United States conducting this study.

"Sixteen years ago, the hepatitis C virus had not even been identified and now there are an estimated 170 million people around the world infected." said Sharon Frey, M.D., professor of internal medicine in the division of infectious disease at Saint Louis University School of Medicine. "It is critical that we develop a vaccine to combat this growing health problem."

The purpose of this research is to study the safety and effectiveness of the Chiron Corp.'s investigational hepatitis vaccine. Although the Chiron vaccine has been given to people in previous studies, this is the first time the vaccine will be tested in humans with a different "adjuvant." (A vaccine adjuvant is a chemical designed to help the body make a better response to vaccines.) Volunteers will be randomly assigned to receive one of the nine different combinations of hepatitis C virus vaccine and adjuvant.

"Officials at the Centers for Disease Control and Prevention believe that approximately 40,000 new cases of hepatitis C infections occur every year," Frey said, "therefore a vaccine to prevent the infection would be an important breakthrough in controlling the spread of the hepatitis C virus."

The study is being conducted by Saint Louis University's Center for Vaccine Development (led by the division of infectious diseases and immunology) in collaboration with Saint Louis University Liver Center (led by the school's division of gastroenterology and hepatology). This research
'"/>

Contact: Joseph Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
3-May-2006


Page: 1 2

Related medicine news :

1. UK and other European countries should introduce universal childhood hepatitis B vaccination
2. Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
3. Cure for hepatitis C announced by VCU researcher
4. The hepatitis C link: Diagnose, treat, transplant
5. Could statins be a new option for hepatitis C patients?
6. Risk of lymphoma increases with hepatitis C virus infection
7. Outcomes for patients with hepatitis B who need liver transplants
8. Interferon-treated hepatitis C patients likely to experience retinopathy
9. Racial differences seen in steatosis in patients with hepatitis C
10. MGH study examines impact of infection with both HIV and hepatitis C virus
11. Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... 26, 2017 , ... Antoine Dental Center is now offering various types of dental ... act as a support for prosthetic teeth, such as crowns, bridges, or dentures. An implant ... a sturdy, lasting new root for the tooth. , Several types of dental implants ...
(Date:6/26/2017)... ... June 26, 2017 , ... Maryland’s ... review of government data released by the United Soybean Board. , Thanks ... soybean farmers have increased their productivity on less land per bushel, the report ...
(Date:6/26/2017)... , ... June 26, 2017 , ... ... staff, and consumers are seeing lots of red these days. According to recent ... charges that result from medical coding errors(1). Some studies point to Electronic Health ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... FCPX LUT ... into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade ... grain for distorted looks, vignettes and blurs to single out subjects, plus much more. ...
(Date:6/25/2017)... ... June 25, 2017 , ... An increase in wetter weather in the Northern ... along with that; a humdinger of an allergy season. A relief from drought conditions ... in misery-causing grass and weed pollen. , “Our patients have been reporting the ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders or ... manufacture, sale and distribution of the AeroForm® Tissue Expander ... its commercial roll-out in the United States ... one hundred (100) medical institutions and health systems, located ... needle-free alternative for women who choose reconstructive surgery following ...
(Date:6/8/2017)...   Responding to Heath Ledger,s father,s recent ... singer Chris Cornell in May, the mental health ... free online psychiatric drug side effects search ... psychotropic drug risks. The father of the ... accidental overdose, has called for tighter rules on prescription drugs. ...
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
Breaking Medicine Technology:
Cached News: